Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologies
2023 · Nature Aging · 112 citations
https://doi.org/10.1038/s43587-023-00405-1
L
Laia Montoliu‐Gaya
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
111
Papers
3.6K
Citations
29
h-index
51
i10-index
Laia Montoliu‐Gaya is an academic researcher from Centre National de la Recherche Scientifique. The author has contributed to research in topics: Alzheimer's disease research and treatments & Dementia and Cognitive Impairment Research & Down syndrome and intellectual disability research. The author has an h-index of 29, co-authored 95 publications.
ORCID: 0000-0001-7684-6318Papers by this author
worksTransitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease
2021 · Journal of Internal Medicine · 102 citations
https://doi.org/10.1111/joim.13332
P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
2021 · EMBO Molecular Medicine · 54 citations
https://doi.org/10.15252/emmm.202115098
Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer’s disease
2022 · Alzheimer s Research & Therapy · 53 citations
https://doi.org/10.1186/s13195-022-01021-8
Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum
2022 · Molecular Neurodegeneration · 51 citations
https://doi.org/10.1186/s13024-022-00586-0
The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho‐tau Round Robin study
2025 · Alzheimer s & Dementia · 42 citations
https://doi.org/10.1002/alz.14508
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat